small molecule

MAXIDEX

DEXAMETHASONE SODIUM PHOSPHATE

Loss of exclusivityloss of exclusivity
CompanyAlconSee this company's full patent-cliff portfolio

Drug detail

Brand nameMAXIDEX
Active ingredientDEXAMETHASONE SODIUM PHOSPHATE
StrengthEQ 0.05% PHOSPHATE
Dosage formOINTMENT
RouteOPHTHALMIC
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MAXIDEX patent cliff — loss of exclusivity — | CliffBio